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Abstract
Background: Very early rehabilitation is expected to improve functional outcomes after stroke, although its
effectiveness has not been fully evaluated. The purpose of this study was to investigate the association between
very early intervention (VEI), and patient outcomes at discharge by using nationwide large data and statistical
treatment for selection bias.
Methods: In this study, we defined VEI as rehabilitation commencing within 3 days of stroke admission. The data
were derived from a nationwide survey of acute-care hospitals conducted in 2007 for designing a reimbursement
scheme and from a concurrent survey on rehabilitation services among a convenient subgroup of hospitals
participating in the above survey. We included patients with a diagnosis code of ischaemic cerebrovascular disease
with acute onset who underwent any rehabilitation services during hospitalisation. Surgery cases, those with no
functional deficit, and those with a severe consciousness deficit upon admission were excluded. A total of 5,482
patients were enrolled from 294 hospitals. To correct for any potential selection bias, we used Friday admission as
an instrumental variable (IV) and conducted a bivariate probit model analysis.
Results: We found that VEI for acute stroke patients was significantly associated with a lesser degree of disability at
discharge. Even after considering endogenous problems due to treatment selection, VEI improved the chance of
reducing disability by 15.3% (p < 0.001). There was no significant association between VEI and in-hospital mortality,
suggesting that VEI was not likely to lead to an adverse outcome.
Conclusions: These data suggest that VEI may lead to a better outcome with no increase in adverse events
compared to delayed rehabilitation.
Background
Stroke remains the third largest cause of mortality in
Japan, resulting in 127,000 deaths per year [1]. Although
the fatality rate has decreased in the last few decades, a
large number of acute survivors still suffer functional
disabilities that lead to the second largest loss of disabil-
ity-adjusted life years (1,078,000 person years) in Japan
[2]. Ischaemic stroke patients represent approximately
two-thirds of all Japanese stroke patients [3]. Recent
clinical studies and meta-analyses have shown that
stroke unit care is effective in reducing mortality and
improving the functional outcome of stroke patients [4].
However, which specific component of stroke unit care
contributes to this benefit remains unclear. Langhorne
et al. showed that two-thirds of stroke units initiated
rehabilitation within 3 days [5], implying the effective-
ness of the very early initiation of rehabilitation (VEI)
on stroke patient outcomes.
There is an ongoing large randomised controlled trial
in Australia to determine the efficacy of VEI among
acute stroke cases [6]. The phase 2 study of the trial
(A Very Early Rehabilitation Trial for stroke (AVERT)
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phase 2; AVERT2) revealed the safety and feasibility of
VEI [7]. The recent Cochrane systematic review of VEI,
however, concluded that the efficacy of VEI remains to
be established [8].
To date, many observational studies have investigated
the association between early initiation of rehabilitation
and patient outcomes. Hayes et al. indicated that stroke
patients who received VEI were likely to have better
recovery of walking ability with a shorter hospital stay,
although the generalisability of this finding may be
limited due to its small sample size (N = 30) that was
collected in a single institute [9].
In their study of 1,716 patients admitted to several
Italian rehabilitation hospitals, Musicco et al. reported
that stroke patients whose rehabilitation started within
7 days of onset were likely to have better functional sta-
tus 6 months after discharge [10]. This study captured a
broader array of patients. Because of the nature of an
observational study, however, their analysis may not
fully eliminate selection bias in treatment assignment
even with adjustment for patient conditions by ordinal
multiple regression analysis [11].
The use of VEI treatment is dependent on the clinical
characteristics of the patients and other factors, both
observed and unobserved, which in turn influence subse-
quent health outcome, cost, and health utility. Thus, it is
difficult to disentangle the effects of treatment per se
from those of unobserved confounders when we use
observational data. In economic studies and recently in
health services research, instrumental variable (IV) meth-
ods have been used to overcome potential selection bias
due to the presence of unobserved confounding factors
in the observational data and to provide consistent esti-
mates of the association between treatment and outcome
for several conditions and treatments [12-15]. Simply
put, IV is a randomly occurring variable associated with
the administration of treatment but is not related to out-
comes. By using an appropriate statistical model that
includes IV, we could statistically control for selection
bias and better evaluate treatment effectiveness. For
example, McGuire et al. used IV methods to assess the
impact of early surgical intervention on the prognosis of
femoral neck fractures [14]. The indication for early sur-
gical intervention may depend on patient characteristics,
which in turn affects patient outcomes. Thus, simple
comparison between only the treatment and control
groups leads to biased results. McGuire and colleagues
used the day of admission, which should randomly occur,
as an instrument to statistically control this selection to
distinguish between the two groups. Using a larger obser-
vational dataset and proper statistical methods such as IV
would, therefore, allow us to determine the association of
VEI treatment with patient’s outcome at discharge, which
shaped the purpose of this study.
Methods
Data source
The data used in this study were derived from a nation-
wide survey conducted in 2007 for developing a case-mix
classification system for acute care and a related reimbur-
sement schedule in Japan [16]. The administrative claims
database that we used for this study was composed of data
compulsorily submitted by the acute care hospitals under
the case-mix-based reimbursement policy. Although
enrolment in this newer reimbursement policy is on
voluntary basis, most of the acute care hospitals in this
country have joined the system. In this database, diagnoses
of diseases related to major resource use during hospitali-
sation are recorded by physicians in charge while referring
to medical charts. The reimbursement rate is set according
to the registered diagnosis. The administrative claims data-
base has several potential biases, including the possibility
of over- or under-reporting due to deceived coding, which
is the same as any administrative claims database. The
data from cases discharged during July and December
2007 were collected in a standardised electronic format
from 965 hospitals (84 academic hospitals and 891 com-
munity hospitals), which account for approximately 30%
of the acute care beds in Japan. The database included
patients’ demographic and clinical information such as
main diagnosis, co-morbidity, and provided procedures,
and claim data on resource use such as the date and
volume of service provision.
Another source of data was a concurrent survey on
rehabilitation services among a convenient subgroup of
hospitals participating in the above national survey (N =
294). The hospitals that voluntarily agreed to join the
additional survey on their rehabilitation service process
for patients with stroke or femoral neck fractures pro-
vided additional detailed information such as the onset
date and the functional levels before onset, at admission,
and on discharge.
We merged these 2 databases using the hospitals’
dummy identification number, admission date, discharge
date, and patient classification system code for further
analysis. Patients’ data were anonymously provided by
the participating hospitals. These 2 projects were
approved by the Ethics Committee of the University of
Occupational and Environmental Health, Fukuoka, Japan.
Data selection
Inclusion and Exclusion Criteria
In this study, we included those patients who were hos-
pitalised for an acute ischaemic stroke event and had
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utilised rehabilitation services, including physical and
occupational therapy, during their hospitalisation. To be
more specific, patients who had the following interna-
tional classification of diseases (ICD-10) codes (G45$,
G46$, I63$, I65$, I66$, I675, I679, I693, or I978) and
were hospitalised within 1 day after onset were selected
from the merged database.
We excluded those who were hospitalised for more
than 180 days, who had intracranial haemorrhages, and
who received a surgical operation since these patients
were likely to have heterogeneous conditions that may
have confounded their chance of functional recovery
and mortality. We also excluded those who were less
likely to have a very early intervention, e.g., patients
with no functional deficit upon admission (modified
Rankin Scale score [mRS] = 0), patients with moderately
severe disability before onset (mRS at pre-admission
≥ 4), and patients in a coma (defined using the Japan
Coma Scale; JCS ≥ 100).
Definitions of variables
We used in-hospital mortality and mRS score at dis-
charge as outcome variables. The mRS was dichoto-
mised as 1 when mRS was 0 or 1, and as 0 otherwise.
Our dataset included the information on the day of
stroke onset and the commencement of the intervention
but not on details of the intervention. With the available
data, we defined VEI in this study as any type of rehabi-
litation performed by physical or occupational therapists
within 3 days after admission for acute cases admitted
within 1 day after onset. Training intensity was defined
as total units (1 unit = 20 minutes) of rehabilitation
training during hospitalisation divided by the length of
hospital stay. We also included the use of edaravone, a
free radical scavenger, because it is widely used for
stroke treatment in Japan, and would affect a patient’s
prognosis. Use of edaravone was labelled ‘yes’ when
more than 1 dose was used during hospitalisation.
Although early intervention using tissue plasminogen
activator (tPA) would also influence outcome [17,18],
we did not include the use of tPA since the prevalence
of its use was < 1% of admitted patients. Finally, we
adopted admission over the weekend as an IV in our
analysis. We defined admission over the weekend as
admissions made on Friday. We assumed that the
chance of receiving VEI would be lower among those
individuals admitted on a Friday because of the reduced
manpower available for rehabilitation therapy on the fol-
lowing Saturday and Sunday.
We included age, gender, co-morbidity index (Charl-
son’s Index [CI]), and pre-admission mRS as potential
confounders that may affect functional and mortality out-
comes. We also obtained functional levels at admission
such as consciousness level (measured using the Japan
Coma Scale), communication disorder, Brunnstrom stage
of the upper and lower extremities, swallowing disorder,
and mRS. Since these functional indices were highly
inter-correlated, we used principal component analysis to
reduce them into 2 independent summary scores: ‘func-
tional severity’ and ‘functional capability’ at admission.
These 2 factors had eigenvalues > 1 and represented
76.4% of the total variance. Larger functional severity
scores indicated more severe functional disability, and
larger functional capability scores meant better functional
levels. These scores have no units.
Statistical analysis
A widely used approach to assess the impact of VEI on
outcomes would involve classifying patients according to
their VEI administration and comparing outcomes
between the 2 groups with risk-adjustment techniques
such as multiple logistic regression models. Although
commonly employed, this approach does not fully solve
residual confounding and treatment selection bias due
to the unmeasured characteristics of the patients and
providers in the case of non-randomised observational
data.
An alternative approach is the use of the IV method.
IV is an observable factor that meets several conditions:
1) randomly present (exogenous); 2) associated with the
likelihood of treatment selection; and 3) no direct asso-
ciation with the targeted outcomes [12]. The day of
admission should be related to service use variation but
not to outcomes except through service variation
[13,14]. McGuire et al. used the day of admission as an
instrument to assess the impact of early surgical inter-
vention on the prognosis of femoral neck fractures [14].
Therefore, in our case, since rehabilitation services are
less likely to be provided over the weekend [19], Friday
admission is considered an effective IV.
To compare our data with those of other cross-sec-
tional observation studies, we initially conducted an
ordinal single equation probit model including VEI as a
major explanatory variable with patients’ characteristics
at admission, training intensity, and use of edaravone as
covariates for risk adjustment. We then used a bivariate
probit (BVP) model to account for Friday admission as
an instrument. To be specific, the first equation pre-
dicted the likelihood of VEI treatment with patient char-
acteristics at admission as covariates and Friday
admission as an instrument. The second stage equation
then regressed the targeted outcomes on VEI use pre-
dicted in the first equation with patient characteristics
at admission, training intensity, and edaravone use as
covariates. Since the quality of rehabilitation services
may vary across institutes, we also conducted a similar
analysis stratified by the existence of a rehabilitation
specialty as a surrogate marker of care quality.
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Results
Patient characteristics
Figure 1 shows the patient selection process. Records of
39,167 patients were successfully merged and 6,882
patients met our inclusion criteria. Due to missing
values in key variables, 1,400 observations were
excluded, resulting in the availability of 5,482 patients
for further analysis (Figure 1). Those patients excluded
due to missing values had a 2.3% higher in-hospital
mortality rate, 4.5% lower prevalence of females, and a 1
year older mean age compared with patients included in
the analysis. The Friday admission rate and co-morbidity
index were similar between the included and excluded
subjects.
Table 1 reports patient characteristics. The average
age was 73.1 (11.7) years, 39.7% were female, and 64.4%
had no functional deficit at pre-admission (mRS = 0).
As for clinical status at admission, 41.6% had a
moderate consciousness disorder (Japan Coma Scale ≥
3), and 17.6% showed a small functional deficit (mRS ≤
1). VEI was administered to 74.2% of patients. Admis-
sion on Friday was observed in 829 patients (15.1%). A
small functional deficit (mRS ≤ 1) that remained at the
time of discharge was observed in 2,365 patients (44.0%)
and the overall in-hospital mortality rate was 1.6%.
Table 2 reports the descriptive statistics of the studied
sample divided by VEI administration. Patients who
received VEI were younger and showed better pre-
admission mRS, a lower functional severity score, and a
worse functional capability score at admission. Patients
with VEI were more likely to have a better mRS at dis-
charge. The in-hospital mortality rate showed no signifi-
cant difference in between the 2 groups. Patients who
received VEI were less likely to be admitted on Friday
compared to those without VEI (12.1% vs. 23.9%,
p < 0.001).
Figure 1 Patient selection. mRS: modified Rankin scale, JCS: Japan coma scale, LOS: length of stay
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Effect of VEI on mRS at discharge
Table 3 presents the results of single probit and BVP
analyses of effects on mRS at discharge. Less disability is
associated with younger age, lower mRS at pre-admis-
sion, lower functional severity score, higher functional
capability score, lower training intensity, and administra-
tion of VEI. VEI was significantly and positively
associated with better mRS at discharge in both models.
The single probit model estimation shows that VEI
improved the chance of reducing disability at the time
of discharge by 4.8% (p = 0.007). The BVP model
showed an even larger reduction, 15.3% (p < 0.001)
Training intensity had a significant negative asso-
ciation with mRS at discharge in both models (-0.015,
Table 1 Descriptive statistics of studied sample (N = 5,482)
Variable name Descriptive analysis* Missing from variables**
Age (years, SD) 73.1 (11.7) 0
Gender (Female %) 2,175 (39.7) 0
mRS at pre-admission (0–1, %) 4,581 (83.6) 807
mRS at admission (0-1, %) 965 (17.6) 746
Consciousness level (JCS; 1-3, %) 3,200 (58.4) 236
Comm. disorder, explanation (Mild, %) 4,279 (78.1) 419
Comm. disorder, understanding (Mild, %) 4,453 (81.2) 426
Brunnstrom stage, upper (Mild/No symptoms, %) 3,694 (67.4) 576
Brunnstrom stage, lower (Mild/No symptoms, %) 3,896 (71.0) 579
Swallowing disorder (Mild, %) 4,262 (77.8) 463
Co-morbidity index (CI; 0-1, %) 2,796 (51.0) 0
Use of edaravone (%) 3,230 (58.9) 0
VEI (%) 4,068 (74.2) 0
Training intensity (unit/day, SD) 1.54 (1.19) 0
mRS at discharge (0-1, %) *** 2,365 (44.0) 818
In-hospital mortality (%) 89 (1.6) 0
Friday admission (%) 829 (5.1) 0
mRS: modified Rankin scale; JCS: Japan coma scale; LOS: length of stay; VEI: very early intervention; CI: Charlson’s index
*: Descriptive analysis presents the number (percent) of categorical variables and the mean (standard deviation) of the continuous variables.
**: Number of missing values in patients who matched the inclusion criteria.
***: mRS at discharge was available for 5,381 patients
Table 2 Comparison of those with and without VEI
VEI (-) N = 1,414 (25.8%) VEI (+) N = 4,068 (74.2%) Univariate analysis
(P value)*
Age in years (SD) 73.6 (11.8) 72.9 (11.7) 0.045
Gender (female) 40.2% 39.5% 0.614
mRS pre-admission
mRS = 0 61.7% 65.3%
mRS = 1 19.7% 19.0% 0.007
mRS = 2 8.6% 8.4%
mRS = 3 10.0% 7.3%
Functional severity score, mean (SD) ¶ 0.24 (1.78) 0.10 (1.69) 0.005
Functional capability score, mean (SD) ¶ -0.12 (1.1) -0.29 (0.99) < 0.001
Co-morbidity index (CI > 1) 48.4% 49.2% 0.629
Use of edaravone 56.5% 59.8% 0.032
Training intensity (unit/day), mean (SD) 1.04 (0.84) 1.71 (1.25) < 0.001
mRS at discharge (0-1) 40.1% 45.3% < 0.001
In-hospital mortality 1.7% 1.6% 0.799
Friday admission 23.9% 12.1% < 0.001
CI: Charlson’s index, mRS: modified Rankin scale, VEI: very early intervention
*: Chi-square test for categorical variables and t-test for continuous variables.
¶: Functional severity score is the principal component of patient severity. Larger values indicate more severe patient conditions. Functional capability score is
the principal component of patient functional capability. Larger values indicate better function.
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p = 0.026 in the single probit model; -0.010, p = 0.031
in the BVP model).
Effect of VEI on in-hospital mortality rate
Table 4 presents the results of single probit and BVP
analyses of VEI on the in-hospital mortality rate. There
was no significant association between VEI and in-hos-
pital mortality in either model. In the BVP model, the
correlation coefficient of the disturbances (r) was not
significant for the likelihood ratio test (r = 0.04 [-0.59,
0.64], p = 0.91).
Training intensity was significantly and negatively
associated with the in-hospital mortality rate in both
models, suggesting that the administration of VEI
reduced mortality by 0.4% in the BVP model (p =
0.031).
Stratified analysis by availability of rehabilitation
specialty services
We conducted a similar analysis stratified by the avail-
ability of rehabilitation specialty services as a proxy
index of service quality. VEI was positively and signifi-
cantly associated with better mRS at discharge among
those with and without access to a specialty service dur-
ing their hospitalisation (data not shown). Interestingly,
training intensity showed a negative and significant asso-
ciation with better mRS at discharge among those with-
out specialty service (marginal effect estimate = -0.281,
p < 0.001), while the association was positive yet non-
significant among those with specialty services (marginal
effect estimate = 0.002, p = 0.797). VEI had no signifi-
cant association with in-hospital mortality, while train-
ing intensity had a negative and significant relationship
with in-hospital mortality in both strata (without speci-
alty service: marginal effect estimate = -0.006, p = 0.001
in the single probit model; with specialty service: mar-
ginal effect estimate = -0.003, p = 0.014 in the single
probit model).
Discussion
Recent consensus guidelines recommend early interven-
tion for acute stroke patients [20], but little evidence
exists regarding the effectiveness of VEI for acute stroke
patients. In the present study, we used IV estimation to
provide insight into this important question using a
large Japanese patient sample.
We found that VEI for acute stroke patients was sig-
nificantly and positively associated with the chance of
better mRS at discharge, even after consideration of
endogenous problems due to treatment selection. Our
findings were basically in agreement with those from
previous observational and interventional studies.
In an observational study by Musicco et al. [10],
delayed initiation of rehabilitation after 7 days since
onset doubled the odds of a severe activity of daily living
(ADL) deficit 6 months after admission. A simple com-
parison between this study and ours is not plausible
because of the different case mix in terms of disease
severity and different contents of rehabilitation interven-
tion. However, this previous finding might suffer from
Table 3 Results of probit model analysis to predict mRS ≦ 1 at discharge
Single probit model Bivariate probit model
Marginal effect (95% C.I.) Marginal effect (95% C.I.)
Age -0.004** (-0.006, -0.003) -0.003** (-0.004, -0.002)
Gender (female) -0.014 (-0.046, 0.018 ) -0.010 (-0.033, 0.014)
mRS pre-admission
mRS = 0 - - -
mRS = 1 -0.055** (-0.092, -0.019) -0.041** (-0.068, -0.014)
mRS = 2 -0.329** (-0.357, -0.301) -0.220** (-0.248, -0.192)
mRS = 3 -0.384** (-0.406, -0.361) -0.257** (-0.287, -0.226)
Functional severity score¶ -0.216** (-0.228, -0.204) -0.155** (-0.168, -0.142)
Functional capability score¶ 0.089** (0.073, 0.104 ) 0.053** (0.041, 0.065)
Co-morbidity index (CI > 2) -0.017 (-0.047, 0.014) -0.010 (-0.033, 0.013)
Use of edaravone -0.013 (-0.044, 0.018 ) -0.009 (-0.031, 0.013)
VEI 0.048** (0.013, 0.084 ) 0.153** (0.072, 0.234)
Training intensity -0.015* (-0.029, -0.002) -0.011* (-0.020, -0.001)
First stage regression
Friday admission -0.076** (-0.092, -0.059)
N = 5,381
In the bivariate probit model, r = -0.30 [-0.51, 0.05], p = 0.024
CI: Charlson’s index; mRS: modified Rankin scale; VEI: very early intervention
¶: Functional severity score is the principal component of patient severity. Larger values indicate more severe patient conditions. Functional capability score is
the principal component of patient functional capability. Larger values indicate better function.
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overestimation of the causal effect of treatment since
early intervention was more likely to be administered to
patients with mild to moderate severity rather than to
those with severe conditions such as coma.
An early report from a recently conducted randomised
controlled trial (AVERT2) also showed that VEI effec-
tively improved ADLs 3 months after onset [7]. The
probability of intact ADLs 3 months after onset among
treatment patients was 9.2% (-12.9, 31.2) higher than
that of the control patients. Thus, the effect size was
smaller than what was observed in the current study.
Again, a simple comparison requires caution because of
the different timing of the functional evaluation.
In the current study, a large population derived from
multiple institutions was used to assess the clinical
impact of VEI. We evaluated patient disability outcome
at discharge since it may better reflect the effect of reha-
bilitation intervention during the hospitalisation period.
We also adopted Friday admission as an IV to correct
for treatment selection bias and unmeasured confound-
ing effects. Friday admission was, as expected, signifi-
cantly and negatively associated with the likelihood of
VEI administration. In the BVP model, the correlation
coefficient of the disturbances (r) demonstrated that the
error term in the prediction model for VEI (or the first
step regression) was significantly associated with that in
the prediction of mRS at discharge (the second step
regression), suggesting that there was an endogenous
relationship between the administration of VEI and vari-
ables predicting mRS at discharge other than VEI. The
positive effect of VEI on disability outcome at discharge
remained significant even after consideration for endo-
genous problems due to treatment selection using the
IV method.
On the other hand, there was no significant associa-
tion between VEI and in-hospital mortality, suggesting
that VEI was not likely to lead to death. A physician’s
decision on whether to administer VEI during the acute
phase of stroke may be dependent on their assessment
of the patient’s need of bed rest. In this study, we
excluded patients with a severe consciousness deficit.
The AVERT2 study also showed that very early rehabili-
tation has no significant association with mortality
among patients who could react to verbal commands.
Thus, it seems that VEI can be safely administered to
those patients with mild to moderate consciousness
disturbances.
Several mechanisms are presumably involved in the
positive effect of VEI on functional outcome, such as
neural plasticity and cortical reorganisation enhanced by
early intervention. The genes responsible for neuronal
growth and synaptogenesis are expressed at their highest
levels during early brain development and decline with
age, but a stroke event re-initiates the increased expres-
sion of these genes for a limited period after stroke [21].
It is suggested that there is a critical period of heigh-
tened neuroplasticity and a critical time window for
early rehabilitation after stroke. Furthermore, stroke
model rats given early rehabilitation (5 or 14 days post-
stroke) displayed significant recovery, whereas rats given
Table 4 Results of probit model analysis to predict in-hospital mortality
Single probit model Bivariate probit model
Marginal effect (95% C.I.) Marginal effect (95% C.I.)
Age (by 10 years) 0.002* ( 0.000, 0.004) 0.002 (-0.000, 0.003)
Gender (Female) -0.000 (-0.004, 0.003) -0.000 (-0.003, 0.002)
mRS pre-admission
mRS = 0 -
mRS = 1 -0.001 (-0.006, 0.003) -0.001 (-0.005, 0.002)
mRS = 2 0.003 (-0.004, 0.010) 0.002 (-0.004, 0.008)
mRS = 3 0.003 (-0.004, 0.010) 0.002 (-0.003, 0.007)
Functional severity score¶ 0.004** (0.003, 0.006) 0.003* (0.001, 0.006)
Functional capability score¶ 0.002* (0.000, 0.003) 0.001 (-0.000, 0.002)
Co-morbidity index (CI > 2) 0.003 (-0.001, 0.006) 0.002 (-0.001, 0.005)
Use of edaravone 0.002 (-0.002, 0.005) 0.001 (-0.002, 0.005)
VEI 0.003 (-0.000, 0.006) 0.001 (-0.013, 0.016)
Training intensity -0.005** (-0.007, -0.003) -0.004* (-0.007, 0.000)
First stage regression
Friday admission -0.001 (-0.002, 0.000)
N = 5,482
In the bivariate probit model: r = 0.04 [-0.59, 0.64], p = 0.91
CI: Charlson’s index; mRS: modified Rankin scale; VEI: very early intervention
¶: Functional severity score indicates the principal component of patient severity. Larger values indicate more severe patient conditions. Functional capability
score is the principal component of patient functional capability. Larger values indicate better function.
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delayed treatment (30 days post-stroke) exhibited little
improvement [22]. Notably, early rehabilitation
increased the dendritic branching of layer V cortical
neurons, whereas rehabilitation that was delayed until
30 days post-stroke had no effect [22]. Early rehabilita-
tion should also prevent disuse syndrome and related
conditions such as pneumonia and decubitus ulcers,
which may also lead to better chance of functional
recovery.
The current findings may have important policy impli-
cations. Stroke is the second largest cause of disability
adjusted life years loss in Japan. Early initiation of reha-
bilitation may be a promising strategy to reduce the
burden of disability and subsequent long-term care
costs. Besides, improved function would lead to higher
quality of life and social productivity among stroke
casualties. Further research on the cost effectiveness of
VEI deserves academic and policy attention.
The strengths of this study include its large dataset of
stroke patients from a large number of hospitals in
Japan and its use of the IV method. In spite of these
strengths, the current study suffers from several limita-
tions. We used mRS as a measure of disability levels.
Since mRS was originally a measure of a person’s ability
to self-care, it may not be a useful measure in hospita-
lised cases. Our dataset did not include detailed infor-
mation on patients’ ADLs, such as Functional
Independence Measure (FIM). The mRS scores may be
less sensitive to changes in functional levels during hos-
pitalisation. In spite of this, we found a significant
impact of VEI, which still supports the effectiveness of
VEI to alleviate a patient’s disability after acute stroke
attack.
Due to a lack of information on hourly period and
details of the rehabilitation therapy, we defined in this
study VEI as intervention commencing within 3 days
after admission, which may prohibit simple comparison
of our findings with those in previous studies. Bernhardt
et al. defined VEI as intervention commencing within 48
hours after stroke onset [6,7]. They also considered VEI
to be any intervention delivered with the aims of redu-
cing the time from stroke onset to first mobilisation and
increasing the amount of out of bed physical activity
[6,7]. Further investigation may be necessary with the
standardized definition of VEI.
Due to voluntary participation, there might be a possi-
bility of sampling bias. We compared hospitals who sub-
mitted both claim and clinical data (and were included
in the analysis, N = 294) with those who submitted
claim data only (N = 681). Most prominent difference
was that in general, included hospitals were more likely
to be high-volume large general hospitals specializing in
acute care of stroke while the excluded hospitals were
more likely to be smaller private facilities providing a
mix of acute and chronic care services. Thus, the pre-
sented results in our analysis may be applicable only to
the larger acute hospitals, and whether VEI exhibits a
similar effect on patient functional outcome in a broader
range of hospitals needs further investigation.
Length of hospital stay (LOS) is also an important
outcome measure of treatment effectiveness. LOS is also
regarded as an confounder because more severe cases
may require a longer LOS. However, as OECD Health
Data shows [23], Japanese hospitals exhibit significantly
longer LOS values compared to hospitals in other
OECD countries, which is attributed to undifferentiated
hospital functions between acute and chronic care, and
consequent ‘hospitalisation due to social reasons’ [24].
LOS is determined not only by patient medical condi-
tions but also by patient social conditions such as avail-
ability of informal care in the household, gender roles,
and regional socioeconomic resources [25]. Since infor-
mation to control for patient and regional socio-
economic conditions was not present in the database,
we chose not to use LOS in our analytic model.
In our analysis, every covariate was associated with
mRS at discharge as expected, except for training inten-
sity during hospitalisation, which was negatively related
to mRS at discharge, a finding that requires some dis-
cussion. Kwakkel et al. reviewed 9 controlled trials and
showed that intensive training was more effective for
ADL recovery [26]. A Japanese epidemiological study
conducted in 2003 by The Japanese Association of
Rehabilitation Medicine also showed that training inten-
sity was positively associated with improved ADLs [27].
A plausible explanation for the inconsistent findings
would be the reverse causation between patient func-
tional outcome and training intensity due to treatment
selection. Ishida et al. [27] reported that patients who
were expected to have better ADL recovery were less
likely to receive intensive rehabilitation. Another expla-
nation might be that training intensity was confounded
by hospital characteristics. Besides, when we stratified
patients by availability of specialty consulting, we
observed a differential impact of training intensity on
patient functional outcomes at discharge.
Furthermore, 1,400 patients were excluded from the
analysis due to missing observations in key variables.
The excluded patients were older, more likely to be
female, and had higher in-hospital mortality rates than
the included patients, which might lead to estimation
bias. The majority of missing values were from patient
severity variables. Three hospitals had a relatively large
patient volume and a higher mortality rate, and they
failed to provide these key variables. These cases would
apparently form the outliers in our sample, and exclu-
sion of these specific hospitals would not substantially
affect our analytic results.
Matsui et al. BMC Health Services Research 2010, 10:213
http://www.biomedcentral.com/1472-6963/10/213
Page 8 of 10
Our analysis did not examine hospital characteristics,
e.g., quality of care, which would have been as influen-
tial on outcomes as patient demographic and clinical
characteristics. In our analysis, we measured the quan-
tity of rehabilitation services but did not have any infor-
mation regarding the quality of services. Instead, we
included specialty consulting as a surrogate marker of
the quality of hospital care and confirmed a similar
effect size of VEI regardless of specialty consultation.
Thus, we believe that the effectiveness of VEI detected
in our analysis might be robust. However, measurement
of the quality of rehabilitation services deserves further
analysis.
Finally, the exclusion criteria we used for the patients
limit the current findings to those patients with mild to
moderate severity. Whether VEI is similarly effective
and safe among patients with more severe conditions
remains an open question. Schweickert et al. conducted
a randomised controlled trial of early intervention
among sedated adults and found that patients with VEI
were more likely to return to independent functional
status upon hospital discharge [28].
Conclusions
We estimated the effect of VEI among patients of acute
ischaemic stroke events in Japan after correcting for
treatment selection bias with instrument variable
method. Our results indicated that VEI was effective for
functional recovery and was safely administered to
ischaemic stroke patients with mild to moderate severity.
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